Get the app!
Back to Trades

Froimson Mark

DirectorCIK 0001709050

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
3
Buy transactions
0
Sell transactions
1
Companies
1
Active
2026

Across 3 filings between 2026, Froimson Mark, Director, has disclosed $4.5M in transactions — all concentrated in Pacira BioSciences, Inc. (PCRX). Their disclosed trades are heavily weighted toward selling — $0 in buys and $10.9K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

3 loaded
Nov 17PCRX
Pacira BioSciences, Inc.
Froimson MarkDirectorDisposed$4.2M
Jun 12PCRX
Pacira BioSciences, Inc.
Froimson MarkDirectorGrant$255.1K
Mar 19PCRX
Pacira BioSciences, Inc.
Froimson MarkDirectorSell$10.9K

3 filings